National Bank of Canada
OCUL icon

National Bank of Canada’s Ocular Therapeutix OCUL Stock Holding History

National Bank of Canada’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06K Buy
+125
New +$1.19K ﹤0.01% 2668
2022
Q3 		– Sell
-2,370
Closed -$10K – 2826
2022
Q2 		$10K Hold
2,370
– – ﹤0.01% 2270
2022
Q1 		$12K Hold
2,370
– – ﹤0.01% 2320
2021
Q4 		$16K Buy
+2,370
New +$18.4K ﹤0.01% 2218

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

National Bank of Canada's OCUL Position: Q1 2026 in Review

National Bank of Canada opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 125 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #2668 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in OCUL as recently as Q2 2022.

National Bank of Canada first reported a position in OCUL in Q4 2021 and has held it in 4 quarters since. The position peaked at $16K in Q4 2021. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • National Bank of Canada held 125 shares of Ocular Therapeutix worth $1.06K as of Q1 2026.
  • Ocular Therapeutix was a new National Bank of Canada position in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2668 holding.
  • National Bank of Canada first reported a position in Ocular Therapeutix in Q4 2021 and has held it in 4 quarters since.
  • National Bank of Canada's Ocular Therapeutix position peaked at $16K in Q4 2021.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.